Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SSKN | Common Stock | Purchase | $724K | +231K | +19.04% | $3.14 | 1.44M | Jul 15, 2024 | Direct | |
holding | SSKN | Common Stock | 1.44M | Jul 15, 2024 | By: Accelmed Growth Partners (GP), L.P. | F1 | |||||
holding | SSKN | Common Stock | 1.44M | Jul 15, 2024 | By: Accelmed Growth Partners (AGP), Ltd. | F1 | |||||
holding | SSKN | Common Stock | 1.44M | Jul 15, 2024 | By: Accelmed Management Ltd. | F1 |
Id | Content |
---|---|
F1 | Shares are held directly by Accelmed Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Partners (GP), L.P., the general partner of Accelmed Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of their pecuniary interest in the shares of common stock held by Accelmed Partners, L.P. |